111 related articles for article (PubMed ID: 1907129)
41. Low-grade astrocytomas: treatment results and prognostic variables.
Medbery CA; Straus KL; Steinberg SM; Cotelingam JD; Fisher WS
Int J Radiat Oncol Biol Phys; 1988 Oct; 15(4):837-41. PubMed ID: 3141317
[TBL] [Abstract][Full Text] [Related]
42. Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation.
Leighton C; Fisher B; Bauman G; Depiero S; Stitt L; MacDonald D; Cairncross G
J Clin Oncol; 1997 Apr; 15(4):1294-301. PubMed ID: 9193320
[TBL] [Abstract][Full Text] [Related]
43. Therapy for supratentorial malignant astrocytomas: survival and possible prognostic factors.
Lai DM; Lin SM; Tu YK; Kao MC; Hung CC
J Formos Med Assoc; 1993 Mar; 92(3):220-6. PubMed ID: 8102273
[TBL] [Abstract][Full Text] [Related]
44. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study.
Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S
Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340
[TBL] [Abstract][Full Text] [Related]
45. Prognosis and treatment of spinal cord astrocytoma.
Minehan KJ; Brown PD; Scheithauer BW; Krauss WE; Wright MP
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):727-33. PubMed ID: 18687533
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy].
Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors in low grade (WHO grade II) gliomas of the cerebral hemispheres: the role of surgery.
Scerrati M; Roselli R; Iacoangeli M; Pompucci A; Rossi GF
J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):291-6. PubMed ID: 8795601
[TBL] [Abstract][Full Text] [Related]
48. Radiation therapy in the management of low-grade supratentorial astrocytomas.
Shaw EG; Daumas-Duport C; Scheithauer BW; Gilbertson DT; O'Fallon JR; Earle JD; Laws ER; Okazaki H
J Neurosurg; 1989 Jun; 70(6):853-61. PubMed ID: 2715812
[TBL] [Abstract][Full Text] [Related]
49. Adult supratentorial low-grade glioma: long-term experience at a single institution.
Bauman G; Fisher B; Watling C; Cairncross JG; Macdonald D
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1401-7. PubMed ID: 19395201
[TBL] [Abstract][Full Text] [Related]
50. Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy.
Marcial-Vega VA; Wharam MD; Leibel S; Clark A; Zweig R; Order SE
Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1419-24. PubMed ID: 2722586
[TBL] [Abstract][Full Text] [Related]
51. Prognostic factors and survival in low grade gliomas of the spinal cord: A population-based analysis from 2006 to 2012.
Diaz-Aguilar D; ReFaey K; Clifton W; Durcanova B; Chen SG; Deen HG; Bydon M; Trifiletti DM; Pichelmann MA; Quiñones-Hinojosa A
J Clin Neurosci; 2019 Mar; 61():14-21. PubMed ID: 30528541
[TBL] [Abstract][Full Text] [Related]
52. Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas.
Watanabe T; Katayama Y; Yoshino A; Fukaya C; Yamamoto T
J Neurooncol; 2005 Mar; 72(1):57-62. PubMed ID: 15803376
[TBL] [Abstract][Full Text] [Related]
53. Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma.
Laperriere NJ; Leung PM; McKenzie S; Milosevic M; Wong S; Glen J; Pintilie M; Bernstein M
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1005-11. PubMed ID: 9719109
[TBL] [Abstract][Full Text] [Related]
54. Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults.
Nakamura M; Konishi N; Tsunoda S; Nakase H; Tsuzuki T; Aoki H; Sakitani H; Inui T; Sakaki T
Oncology; 2000 Feb; 58(2):108-16. PubMed ID: 10705237
[TBL] [Abstract][Full Text] [Related]
55. Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery.
van Veelen ML; Avezaat CJ; Kros JM; van Putten W; Vecht C
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):581-7. PubMed ID: 9598670
[TBL] [Abstract][Full Text] [Related]
56. Clinical outcome of supratentorial astrocytoma WHO grade II.
Peraud A; Ansari H; Bise K; Reulen HJ
Acta Neurochir (Wien); 1998; 140(12):1213-22. PubMed ID: 9932120
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcomes and prognostic factors in patients with supratentorial low-grade gliomas.
Yeh SA; Ho JT; Lui CC; Huang YJ; Hsiung CY; Huang EY
Br J Radiol; 2005 Mar; 78(927):230-5. PubMed ID: 15730987
[TBL] [Abstract][Full Text] [Related]
58. Prognostic implications of p53 overexpression in supratentorial astrocytic tumors.
Chozick BS; Pezzullo JC; Epstein MH; Finch PW
Neurosurgery; 1994 Nov; 35(5):831-7; discussion 837-8. PubMed ID: 7838330
[TBL] [Abstract][Full Text] [Related]
59. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.
Grossman SA; Wharam M; Sheidler V; Kleinberg L; Zeltzman M; Yue N; Piantadosi S
J Clin Oncol; 1997 Jul; 15(7):2596-603. PubMed ID: 9215830
[TBL] [Abstract][Full Text] [Related]
60. Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis.
Bauman G; Lote K; Larson D; Stalpers L; Leighton C; Fisher B; Wara W; MacDonald D; Stitt L; Cairncross JG
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):923-9. PubMed ID: 10571199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
